Abstract

CD8+CD28− T suppressor cells (Ts) have been recently documented to play an important role in alloimmunity. Therefore, understanding and optimizing the conditions under which these cells are generated and/or expanded would greatly facilitate further research and potential clinical use. In this study, we describe rapid expansion of human allospecific CD8+CD28− Ts cells through coculture of CD8+ T cells with human leukocyte antigen-mismatched donor antigen-presenting cells plus IL-15 in a relative short period of time in vitro. Interestingly, IL-15 promotes the expansion of CD8+CD28− Ts cells through several parallel mechanisms. The expanded CD8+CD28− Ts cells upregulate expression of CD132, CD25, and programmed cell death protein 1 (PD-1), but downregulate expression of CD122, GZM-B, and perforin, while exhibiting no cytotoxicity. Most importantly, the expanded CD8+CD28− Ts cells vigorously inhibit CD4+ T cells proliferation in a contact-dependent and donor-specific manner both in vitro and in vivo. Interestingly, the co-inhibitory molecules PD-1 and programmed death-ligand 1 play an obligatory role in the mechanisms of CD8+CD28− Ts cells suppression. Taken together, our study report novel methodology for IL-15-induced expansion of human CD8+CD28− Ts cells and possible mechanisms. These findings may facilitate understanding of transplant rejection and promote clinical application of CD8+CD28− Ts cell-based strategies for inducing and monitoring transplant tolerance in the future.

Highlights

  • The indefinite need for non-specific immunosuppressive drugs posttransplantation brings a series of unwanted side effects, such as infectious diseases and malignancies, which often increase the mortality of the patients

  • The total number of CD8+CD28− T suppressor cells (Ts) cells increased by 23.42 ± 5.43-fold after 9 days culture in the presence of IL-15 (p < 0.001), whereas this increase did not occur in the absence of IL-15 (Figure 1C)

  • CD8+CD28− T suppressor cells have emerged as an important modulator of alloimmunity and autoimmunity and have been reported to be generated in vitro after multiple rounds of stimulation of human peripheral blood mononuclear cell (PBMC) with either allogeneic- [27] or xenogeneic-donor antigen-presenting cells (APCs) [28]

Read more

Summary

Introduction

The indefinite need for non-specific immunosuppressive drugs posttransplantation brings a series of unwanted side effects, such as infectious diseases and malignancies, which often increase the mortality of the patients. IL-15 Expanded CD8+CD28− Ts Suppress Allosepcificly induction of alloantigen specific tolerance may hold promise for the best therapeutic strategies for transplant patients in the future. CD4+ and CD8+ regulatory T cell subsets have been found to play an important role in the induction and maintenance of transplant tolerance [4,5,6]. CD4+CD25+Foxp3+ regulatory T cells (Tregs) are most frequently reported and have been documented to play an important role in various diseases and transplant tolerance [7]. Several CD8+ Tregs population with different markers have been reported. Natural CD8+ Tregs marked with CD8+CD25+, CD8+CD122+, or CD8+CXCR3+ [9,10,11] and induced CD8+ Tregs bear various phenotypic characteristics, such as CD28−, CD56+, CD57+, CTLA4+, CD103+, CD25+Foxp3+, or LAG3+CCL4+ [12,13,14,15] were reported in different systems

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call